Recent changes

Jump to: navigation, search

Track the most recent changes to the wiki on this page.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 06:13, 23 January 2020
   

22 January 2020

N    20:47  User talk:Jwarner‎ (diff | hist) . . (+116). . Jwarner (talk | contribs) (Created page with "The page you'd need to edit for the banner is: https://hemonc.org/w/index.php?title=MediaWiki:Sitenotice&action=edit")
 m   17:41  Chronic lymphocytic leukemia‎ (diff | hist) . . (+2,732). . Jwarner (talk | contribs)
 m   16:42  Hepatocellular carcinoma‎ (diff | hist) . . (-1). . Jwarner (talk | contribs) (Regimen {{#subobject:f3a095|Variant=1}})
 m   16:41  HemOnc vocabulary concepts‎‎ (6 changes | history) . . (+2,036). . [Jwarner‎ (6×)]
 m    16:41 (cur | prev) . . (+346). . Jwarner (talk | contribs) (Study-level concepts)
 m    16:36 (cur | prev) . . (+474). . Jwarner (talk | contribs) (Component-level concepts)
 m    13:55 (cur | prev) . . (+345). . Jwarner (talk | contribs) (Regimen-level concepts)
 m    13:30 (cur | prev) . . (+316). . Jwarner (talk | contribs) (Condition-level concepts)
 m    13:23 (cur | prev) . . (+37). . Jwarner (talk | contribs)
 m    13:21 (cur | prev) . . (+518). . Jwarner (talk | contribs)
 m   12:45  Regimen classes‎‎ (2 changes | history) . . (+118). . [Jwarner‎ (2×)]
 m    12:45 (cur | prev) . . (+85). . Jwarner (talk | contribs) (Trastuzumab-based regimen)
 m    12:44 (cur | prev) . . (+33). . Jwarner (talk | contribs) (Endocrine-based regimen)
     12:24  Myelodysplastic syndrome‎‎ (11 changes | history) . . (+5,804). . [Jwarner‎ (11×)]
 m    12:24 (cur | prev) . . (+2,208). . Jwarner (talk | contribs)
 m    12:17 (cur | prev) . . (+2,646). . Jwarner (talk | contribs) (Luspatercept monotherapy {{#subobject:8dgac1|Regimen=1}})
 m    12:17 (cur | prev) . . (-2,621). . Jwarner (talk | contribs) (Placebo)
 m    12:16 (cur | prev) . . (+2,994). . Jwarner (talk | contribs) (Erythropoietin monotherapy {{#subobject:9uyac1|Regimen=1}})
 m    12:15 (cur | prev) . . (-2,949). . Jwarner (talk | contribs) (Epoetin & Lenalidomide {{#subobject:495acc|Regimen=1}})
 m    12:15 (cur | prev) . . (+7,531). . Jwarner (talk | contribs) (Luspatercept monotherapy {{#subobject:8dgac1|Regimen=1}})
 m    12:14 (cur | prev) . . (-7,531). . Jwarner (talk | contribs) (Lenalidomide monotherapy {{#subobject:dfbcc0|Regimen=1}})
      12:13 (cur | prev) . . (+1,476). . Jwarner (talk | contribs)
 m    12:07 (cur | prev) . . (+211). . Jwarner (talk | contribs) (Guidelines)
 m    12:06 (cur | prev) . . (+80). . Jwarner (talk | contribs) ("How I treat")
      12:02 (cur | prev) . . (+1,759). . Jwarner (talk | contribs) (First-line therapy)
N    11:55  Luspatercept (Reblozyl)‎ (diff | hist) . . (+1,095). . Jwarner (talk | contribs) (Created page with "==Mechanism of action== From the NCI Drug Dictionary: A soluble, recombinant fusion protein composed of a modified form of the extracellular domain of human activin receptor t...")
 m   11:53  Epoetin alfa (Procrit)‎ (diff | hist) . . (+75). . Jwarner (talk | contribs) (References)
 m   11:31  Drug index‎ (diff | hist) . . (+4). . Jwarner (talk | contribs) (L)

21 January 2020

     22:13  Follicular lymphoma‎‎ (2 changes | history) . . (+3,574). . [Jwarner‎; Alikhaki‎]
 m    22:13 (cur | prev) . . (+849). . Jwarner (talk | contribs)
      20:10 (cur | prev) . . (+2,725). . Alikhaki (talk | contribs) (Relapsed or refractory, non-randomized or retrospective data: Added duvelisib for relapsed/refractory disease (DYNAMO study)) (Tag: Visual edit)
 m   22:01  MediaWiki:Sitenotice‎ (diff | hist) . . (-601). . Dryang (talk | contribs) (Blood article notice no longer needed)
 m   19:58  Prostate cancer‎‎ (3 changes | history) . . (+5,460). . [Jwarner‎ (3×)]
 m    19:58 (cur | prev) . . (+14). . Jwarner (talk | contribs)
 m    19:56 (cur | prev) . . (+4,094). . Jwarner (talk | contribs)
 m    15:44 (cur | prev) . . (+1,352). . Jwarner (talk | contribs) (Cabazitaxel & Prednisone {{#subobject:23 |Regimen=1}})
 m   19:45  Esophageal cancer‎ (diff | hist) . . (+8). . Jwarner (talk | contribs) (Fluorouracil, Paclitaxel, RT {{#subobject:52e768|Regimen=1}})
 m   16:58  Prostate cancer - historical‎ (diff | hist) . . (-12). . Jwarner (talk | contribs) (Castration)
 m   16:53  Ontology‎ (diff | hist) . . (+13). . Jwarner (talk | contribs)

20 January 2020

 m   21:46  Hepatocellular carcinoma‎‎ (2 changes | history) . . (+1,986). . [Jwarner‎ (2×)]
 m    21:46 (cur | prev) . . (+501). . Jwarner (talk | contribs)
 m    21:38 (cur | prev) . . (+1,485). . Jwarner (talk | contribs) (First-line therapy for advanced or metastatic disease)
 m   21:14  T-cell prolymphocytic leukemia‎ (diff | hist) . . (-23). . Jwarner (talk | contribs)

18 January 2020

 m   22:26  Ovarian cancer‎ (diff | hist) . . (+2,765). . Jwarner (talk | contribs)
 m   21:54  Renal cell carcinoma‎‎ (2 changes | history) . . (+3,631). . [Jwarner‎ (2×)]
 m    21:54 (cur | prev) . . (+26). . Jwarner (talk | contribs) (Regimen {{#subobject:9d436d|Variant=1}})
 m    21:52 (cur | prev) . . (+3,605). . Jwarner (talk | contribs)
 m   21:09  Editing test page‎ (diff | hist) . . (+729). . Jwarner (talk | contribs) (BEACOPP 4+4)
 m   17:52  Multiple myeloma, relapsed-refractory‎ (diff | hist) . . (+1,620). . Jwarner (talk | contribs)

17 January 2020

     21:47  Non-small cell lung cancer, EGFR-mutated‎‎ (2 changes | history) . . (+4,648). . [Jwarner‎ (2×)]
 m    21:47 (cur | prev) . . (+2,169). . Jwarner (talk | contribs) (Advanced or metastatic disease, EGFR inhibitor-naive)
      21:40 (cur | prev) . . (+2,479). . Jwarner (talk | contribs) (Gefitinib monotherapy {{#subobject:fb3998|Regimen=1}})
     14:01  Esophageal cancer‎‎ (6 changes | history) . . (+1,891). . [Jwarner‎ (6×)]
 m    14:01 (cur | prev) . . (+154). . Jwarner (talk | contribs) (Definitive therapy)
 m    13:58 (cur | prev) . . (-28). . Jwarner (talk | contribs) (Fluorouracil & Paclitaxel {{#subobject:58ub68|Regimen=1}})
      13:58 (cur | prev) . . (+1,818). . Jwarner (talk | contribs) (Consolidation after definitive therapy)
 m    13:54 (cur | prev) . . (+88). . Jwarner (talk | contribs) (Fluorouracil, Paclitaxel, RT {{#subobject:52e768|Regimen=1}})
 m    13:53 (cur | prev) . . (-152). . Jwarner (talk | contribs) (Fluorouracil, Paclitaxel, RT {{#subobject:52e768|Regimen=1}})
 m    13:48 (cur | prev) . . (+11). . Jwarner (talk | contribs) (Nivolumab monotherapy {{#subobject:10ee99|Regimen=1}})